Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials ...

New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...

Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine in patients with relapsed and/or refractory AML; ...

The collaboration aims to streamline trial processes, drive advancements, and foster innovation in healthcare research.

A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic ...

( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ: BIOA) ...

Significant Improvement in Skin Appearance Observed in Pediatric Study after Only 12 Days of Dosing with QRX003 ...

UB researchers find that feedback from Community Engagement Studio sessions can have a major impact on their studies.

New York, New York-- (Newsfile Corp. - December 17, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ: BIOA) for potential ...

ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients ...

Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after Only ...

A study published in JAMA Network Open found that cannabidiol (CBD) may alleviate anxiety in women with advanced breast ...